Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivar Roots

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|December 21, 2002
Association between the N-acetylation genetic polymorphism and bronchial asthmaMuradiye Nacak, A Sükrü Aynacioglu, Ayten Filiz, et al.
Pharmacogenetics|September 30, 2003
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Julia Kirchheiner, Christian Klein, Ingolf Meineke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypesRolf Kaiser, Orhan Sezer, Anja Papies, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokineticsIsabella Gashaw, Julia Kirchheiner, Mark Goldammer, et al.
Biochemical Pharmacology|March 26, 2004
Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acidDieter Schwarz, Pyotr Kisselev, Spencer S Ericksen, et al.
Planta Medica|April 28, 2005
No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extractGerhard Arold, Frank Donath, Agathe Maurer, et al.
Pharmacogenetics and Genomics|February 1, 2007
Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genesKatrin Bühler, Mike Ufer, Alexis Müller-Marbach, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum )Andreas Johne, Jürgen Schmider, Jürgen Brockmöller, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamicsJulia Kirchheiner, Claudia Heesch, Steffen Bauer, et al.
Clinical Chemistry|January 31, 2004
Identification of twelve polymorphisms in the endothelin-1 gene by use of fluorescently labeled oligonucleotides and PCR with restriction fragment polymorphism analysisKonstanze Diefenbach, Farhad Arjomand Nahad, Christian Meisel, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|December 21, 2002
Association between the N-acetylation genetic polymorphism and bronchial asthmaMuradiye Nacak, A Sükrü Aynacioglu, Ayten Filiz, et al.
Pharmacogenetics|September 30, 2003
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Julia Kirchheiner, Christian Klein, Ingolf Meineke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypesRolf Kaiser, Orhan Sezer, Anja Papies, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokineticsIsabella Gashaw, Julia Kirchheiner, Mark Goldammer, et al.
Biochemical Pharmacology|March 26, 2004
Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acidDieter Schwarz, Pyotr Kisselev, Spencer S Ericksen, et al.
Planta Medica|April 28, 2005
No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extractGerhard Arold, Frank Donath, Agathe Maurer, et al.
Pharmacogenetics and Genomics|February 1, 2007
Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genesKatrin Bühler, Mike Ufer, Alexis Müller-Marbach, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum )Andreas Johne, Jürgen Schmider, Jürgen Brockmöller, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamicsJulia Kirchheiner, Claudia Heesch, Steffen Bauer, et al.
Clinical Chemistry|January 31, 2004
Identification of twelve polymorphisms in the endothelin-1 gene by use of fluorescently labeled oligonucleotides and PCR with restriction fragment polymorphism analysisKonstanze Diefenbach, Farhad Arjomand Nahad, Christian Meisel, et al.
Pageof 10